What are the most serious or life-threatening complications of neuromyelitis optica that require immediate attention?

One of the most serious complications is muscle weakness that can make breathing difficult, potentially leading to life-threatening respiratory failure. Other severe symptoms include paralysis of the arms and legs, and loss of bladder and bowel control due to transverse myelitis.

What can individuals with the relapsing form of neuromyelitis optica expect regarding their symptoms over time?

The relapsing form, which is the most common, involves recurrent episodes of optic neuritis and transverse myelitis that can occur months or years apart. While there is usually some recovery between episodes, most affected individuals eventually develop permanent muscle weakness and vision impairment.

What are the key differences between optic neuritis and transverse myelitis in neuromyelitis optica?

Optic neuritis involves inflammation of the nerve connecting the eye to the brain, causing eye pain and vision loss in one or both eyes. Transverse myelitis is inflammation of the spinal cord, leading to weakness, numbness, and paralysis of the arms and legs, sensory disturbances, and issues with bladder and bowel control.

Neuromyelitis optica

Neuromyelitis optica is an autoimmune disorder of the central nervous system characterized by inflammation of the optic nerves and spinal cord, leading to vision loss and muscle weakness.

Overview

Neuromyelitis optica is an autoimmune disorder that affects the nerves of the eyes and the central nervous system, which includes the brain and spinal cord. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In neuromyelitis optica, this autoimmune attack causes inflammation of the nerves, and the resulting damage leads to the characteristic signs and symptoms of the condition.

Symptoms

The condition is primarily characterized by two major complications:

Optic Neuritis: Inflammation of the nerve that carries information from the eye to the brain. This causes eye pain and vision loss, which can occur in one or both eyes.
Transverse Myelitis: Inflammation of the spinal cord. This inflammation damages the spinal cord, often causing a lesion that extends the length of three or more bones of the spine. It can also damage myelin, the protective covering that promotes efficient nerve impulse transmission. Transverse myelitis causes weakness, numbness, and paralysis of the arms and legs. Other effects include sensory disturbances, loss of bladder and bowel control, uncontrollable hiccupping, and nausea. Muscle weakness may also make breathing difficult, leading to life-threatening respiratory failure.

Forms of the Disorder

There are two primary forms of neuromyelitis optica:

Relapsing Form: The most common form, characterized by recurrent episodes of optic neuritis and transverse myelitis that can occur months or years apart. While there is usually partial recovery between episodes, most affected individuals eventually develop permanent muscle weakness and vision impairment. This form affects approximately nine times more women than men.
Monophasic Form: A less common form that causes a single episode of the condition lasting several months. Affected individuals can still experience lasting muscle weakness, paralysis, and vision loss. This form affects men and women equally.

The onset of either form can occur from childhood to adulthood, though it most frequently begins in a person's forties. Approximately one-quarter of individuals with neuromyelitis optica also have symptoms of another autoimmune disorder, such as myasthenia gravis, systemic lupus erythematosus, or Sjögren syndrome. Some scientists believe that a condition described in Japanese patients as optic-spinal multiple sclerosis is the same as neuromyelitis optica.

Frequency

Neuromyelitis optica affects approximately 1 to 2 per 100,000 people worldwide. Women are affected by this condition more frequently than men.

Causes

No specific genes associated with neuromyelitis optica have been identified. However, a small percentage of affected individuals have an affected family member, suggesting genetic changes may increase susceptibility. The inheritance is thought to be complex, involving multiple environmental and genetic factors.

The aquaporin-4 protein (AQP4), which is highly abundant in the central nervous system, plays a key role in the disorder. Approximately 70 percent of people with neuromyelitis optica produce an autoantibody (an immune protein that mistakenly attacks normal body tissue) called NMO-IgG or anti-AQP4.

When the NMO-IgG autoantibody binds to the aquaporin-4 protein, it activates the complement system, a group of immune proteins that trigger inflammation and destroy pathogens. This activation leads to the inflammation of the optic nerve and spinal cord. Levels of the NMO-IgG autoantibody are high during active episodes and decrease between episodes with treatment, though the exact triggers for the start or end of episodes remain unclear.

Inheritance

Neuromyelitis optica is usually not inherited. In rare cases where the condition is passed through generations in families, the inheritance pattern remains unknown.

Other Names for This Condition

Devic disease
Devic neuromyelitis optica
Devic syndrome
Devic's disease
Optic-spinal MS
Opticospinal MS